|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1981-2-26
|
|
pubmed:abstractText |
Combination of the beta-adrenergic blocking agent visken with glucagon in the acute period of myocardial infarction possesses higher antiarrhythmic activity with a negligible cardiodepressive effect as compared to that of isolated administration of visken and leads to a decrease in the excessive production of catecholamines and glucocorticoids in the blood.
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0022-9040
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
35-40
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:6108378-Adrenergic beta-Antagonists,
pubmed-meshheading:6108378-Adult,
pubmed-meshheading:6108378-Aged,
pubmed-meshheading:6108378-Anti-Arrhythmia Agents,
pubmed-meshheading:6108378-Arrhythmias, Cardiac,
pubmed-meshheading:6108378-Catecholamines,
pubmed-meshheading:6108378-Drug Evaluation,
pubmed-meshheading:6108378-Drug Therapy, Combination,
pubmed-meshheading:6108378-Female,
pubmed-meshheading:6108378-Glucagon,
pubmed-meshheading:6108378-Glucocorticoids,
pubmed-meshheading:6108378-Hemodynamics,
pubmed-meshheading:6108378-Humans,
pubmed-meshheading:6108378-Male,
pubmed-meshheading:6108378-Middle Aged,
pubmed-meshheading:6108378-Myocardial Infarction,
pubmed-meshheading:6108378-Pindolol
|
|
pubmed:year |
1980
|
|
pubmed:articleTitle |
[Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct].
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract,
Case Reports
|
